Didanosine - 65862-311-30 - (Didanosine)

Alphabetical Index


Drug Information of Didanosine

Product NDC: 65862-311
Proprietary Name: Didanosine
Non Proprietary Name: Didanosine
Active Ingredient(s): 200    mg/1 & nbsp;   Didanosine
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Didanosine

Product NDC: 65862-311
Labeler Name: Aurobindo Pharma Limited
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA090094
Marketing Category: ANDA
Start Marketing Date: 20080924

Package Information of Didanosine

Package NDC: 65862-311-30
Package Description: 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-311-30)

NDC Information of Didanosine

NDC Code 65862-311-30
Proprietary Name Didanosine
Package Description 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (65862-311-30)
Product NDC 65862-311
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Didanosine
Dosage Form Name CAPSULE, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20080924
Marketing Category Name ANDA
Labeler Name Aurobindo Pharma Limited
Substance Name DIDANOSINE
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of Didanosine


General Information